Determining the Need for Additional Testing With Quantiferon TB Gold in Patients With Positive Tuberculin Skin Tests and a History of BCG Vaccination.

Arumairaj, Antony J; Park, Hansang; Quesada, Fernando; Altonen, Brian; Chaudhari, Shobhana; Mattana, Joseph; Habtes, Imnett

Arumairaj, Antony J; Park, Hansang; Quesada, Fernando; Altonen, Brian; Chaudhari, Shobhana; Mattana, Joseph; Habtes, Imnett.

Afiliação

Arumairaj AJ; Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Park H; Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Quesada F; Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Altonen B; Biostatistics and Epidemiology, New York City Health and Hospitals Corporation, New York, USA.
Chaudhari S; Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Mattana J; Internal Medicine, New York Medical College, Metropolitan Hospital Center, New York, USA.
Habtes I; Internal Medicine, Division of Pulmonary and Critical Care, New York Medical College, Metropolitan Hospital Center, New York, USA.

Cureus ; 15(5): e39272, 2023 May.

Article em En | MEDLINE | ID: mdl-37342742

Palavras-chave

bcg vaccination; cross-reactivity; high tb burden; latent tuberculosis infection; mycobacterium tuberculosis; quantiferon tb gold; tuberculin skin test

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google